[深圳]深圳理工大学先进治疗研究院

职位：特聘教授|特聘副教授
发布时间：2026-08-26
工作地点：深圳 其它
信息来源：高校人才网
职位类型：全职
专业标签：生物科学 生物医学 基础医学 药学
职位描述
深圳理工大学先进治疗研究院2026年招聘启事

共计2个岗位，招 若干人

科研启动费

基本信息

发布时间：2026-08-25

截止日期：详见正文

学历要求：博士研究生

需求学科（供参考）：
药学, 生物学, 基础医学, 生物医学工程

展开

公告详情

一、学校介绍

I. About the University

深圳理工大学是深圳市人民政府举办的公办高校，于2024年5月获教育部批复设立。学校依托中国科学院深圳先进技术研究院优质丰厚的科教产教资源，以"高起点、高水平、高标准、高质量"为建设导向，致力于打造一流新型研究型大学。学校立足深圳这座充满创新活力的城市，以推动高水平科技自立自强、自主培养国家亟需拔尖创新人才为目标，借鉴世界一流理工科大学办学模式，践行产教融合、科教融汇理念，通过"学院、研究院、书院"三院一体育人体系及学术、工程、创业三轨培养模式，开展精英式本科教育，因材施教培育优秀科学家、卓越工程师和创新企业家。

Shenzhen University of Advanced Technology (SUAT) is a public university founded by the Shenzhen Municipal People's Government, officially approved by the Ministry of Education in May 2024. Leveraging the rich scientific, educational, and industrial resources of the Shenzhen Institute of Advanced Technology, Chinese Academy of Sciences, SUAT is committed to building a world-class new-type research university under the guiding principles of "high starting point, high level, high standard, and high quality." Rooted in Shenzhen, a city brimming with innovative vitality, SUAT aims to advance high-level scientific and technological self-reliance and independently cultivate top-notch innovative talents urgently needed by the nation. Drawing on the educational models of world-class science and engineering universities and practicing the integration of industry and education as well as science and education, SUAT adopts an integrated "College, Research Institute, and Academy" three-in-one education system and a three-track training model encompassing academic, engineering, and entrepreneurial pathways. It delivers elite undergraduate education and cultivates outstanding scientists, excellent engineers, and innovative entrepreneurs through personalized instruction.

二、先进治疗研究院（筹）介绍

II. About the Institute of Advanced Therapeutics (in preparation)

先进治疗研究院（筹）以模块化、可放大的先进治疗技术产品转化为引擎，致力于为全球患者提供颠覆性疾病治疗解决方案。研究院重点布局罕见病的可治愈性治疗与重大疑难病的突破性治疗两大方向，搭建细胞治疗产品线、基因治疗产品线、核酸药物产品线、靶向递送工程、罕见病模型与验证五大核心研发板块；依托完备的组织架构体系设立三个转化中心包括：细胞治疗产品开发中心覆盖细胞分化、基因编辑、质量控制、临床前评价全链条研发工作；核酸药物与基因治疗中心开展载体优化、mRNA序列设计、ASO筛选等核心技术研发；转化医学与注册事务中心负责IIT/IND申报、IT数据管理、临床合规建设、注册路径规划。同时配套疾病模型与药效评价平台、工艺放大与质控开发平台两大赋能支撑平台作为底层保障，前者构建精准疾病模型与人源化模型支撑药效评估，后者打通从实验室研究到GMP规模化生产转化的关键环节。研究院整合细胞治疗、基因治疗、核酸药物、靶向递送等前沿技术，打通基础研究、技术开发、临床前评价、转化注册、产业化放大完整链条，面向罕见病与重大疑难疾病开发新一代先进治疗药物，推动前沿生物技术落地转化，诚邀有志于先进治疗领域的科研与转化人才加入。

The Institute of Advanced Therapeutics (IAT, in preparation) is driven by the translation of modular, scalable advanced therapy products and is committed to providing disruptive therapeutic solutions for patients worldwide. The Institute focuses on two major directions: curative therapies for rare diseases and breakthrough therapies for major refractory diseases. It has established five core R&D segments: cell therapy product line, gene therapy product line, nucleic acid drug product line, engineering of targeted delivery systems, and rare disease models and validation. Supported by a comprehensive organizational structure, the Institute houses three product development and translation centers: the Cell Therapy Product Development Center, which covers the full R&D chain of cell differentiation, gene editing, quality control, and preclinical evaluation; the Nucleic Acid Drug and Gene Therapy Center, which conducts core technology R&D including vector optimization, mRNA sequence design, and ASO screening; and the Translational Medicine and Regulatory Affairs Center, which handles IIT/IND submissions, IT data management, clinical compliance development, and regulatory pathway planning. Two enabling support platforms serve as the foundational infrastructure: the Disease Model and Efficacy Evaluation Platform, which builds precise disease models and humanized models to support efficacy assessment, and the Process Scale-up and Quality Control Development Platform, which bridges the critical transition from laboratory research to GMP-scale manufacturing. Integrating cutting-edge technologies such as cell therapy, gene therapy, nucleic acid drugs, and targeted delivery, the Institute spans the complete chain from basic research, technology development, preclinical evaluation, translational registration, to industrial scale-up. It develops next-generation advanced therapy drugs for rare and major refractory diseases and promotes the translation of cutting-edge biotechnology. We sincerely invite scientific and translational talents dedicated to the field of advanced therapeutics to join us.

主要研究方向

Key Research Areas

1. 干细胞与基因治疗：干细胞、基因编辑（CRISPR等）、核酸（ASO、RNA等）技术在罕见病与重大疑难病中的应用；

1. Stem cell and gene therapy: applications of stem cells, gene editing (CRISPR, etc.), and nucleic acid (ASO, RNA, etc.) technologies in rare and major refractory diseases;

2. 免疫细胞治疗：工程化免疫细胞（包括MSC、CAR-T等）的开发与优化；

2. Immune cell therapy: development and optimization of engineered immune cells (including MSC, CAR-T, etc.);

3. 病毒/非病毒治疗载体的设计与递送系统开发；

3. Design of viral/non-viral therapeutic vectors and development of delivery systems;

4. 合成生物学与转化：利用合成生物学技术（基因线路、生物传感器）设计智能细胞及基因药物；

4. Synthetic biology and translation: designing smart cells and gene drugs using synthetic biology technologies (gene circuits, biosensors);

5. 细胞制造与标准化：细胞治疗产品的GMP标准化工艺开发与质量控制。

5. Cell manufacturing and standardization: GMP-standardized process development and quality control for cell therapy products.

招聘岗位及要求

Positions and Requirements

特聘教授

Research Professor

应已在相关的学术领域拥有持续性、高水平的学术产出和广泛的学术影响力，具有成为学科领域领军人物的潜力，有一定的国际知名度；一般应为在海内外知名大学或科研机构工作的独立PI。

Candidates should have sustained, high-level academic output and broad academic influence in the relevant field, demonstrate the potential to become a leading figure in the discipline, and possess a degree of international recognition. Typically, candidates should be independent PIs working at renowned universities or research institutions in China or abroad.

特聘副教授

Associate Professor

应已获得较为优秀的学术成果，显示出了较强的学术影响力和发展能力，其成果已经被国内外学术界认可；一般应为40岁以内，有独立发展的能力和持续发展的潜力的青年人才。

Candidates should have achieved outstanding academic results, demonstrated strong academic influence and development capacity, with their work recognized by the academic community both domestically and internationally. Typically, candidates should be young talents under 40 years of age with the ability for independent development and the potential for sustained growth.

任职条件

Qualifications

1. 已取得本领域相关专业博士学位，具有博士后经历优先；

1. A doctoral degree in a relevant field; postdoctoral experience is preferred;

2. 学科专业方向：生物学、细胞治疗、基因治疗、核酸药物、靶向递送等前沿研究方；

2. Disciplinary expertise: cutting-edge research areas such as biology, cell therapy, gene therapy, nucleic acid drugs, and targeted delivery;

3. 在本领域内发表过有影响力的论文或者，具有国家级或省部级重大科研项目申请、主持工作经验者；

3. Published influential papers in the field, with experience in applying for or leading national or provincial/ministerial major scientific research projects.

4. 具有一定的授课经验，能独立从事学术研究的能力及浓厚的学术兴趣、刻苦的钻研精神和开创性的学术思维；

4. Some teaching experience, with the ability to independently conduct academic research, strong academic interest, diligent research spirit, and pioneering academic thinking;

5. 承担课程教学，参与研究院的教学课程、产教融合平台建设；

5. Undertake course teaching and participate in the development of the Institute's teaching curriculum and industry-education integration platforms;

6. 独立领导、完成科研项目研究，发表高水平研究论文，申请专利；

6. Independently lead and complete research projects, publish high-level research papers, and apply for patents;

7. 工作态度认真，责任心强，沟通能力良好，具备一定的团队组织能力。

7. Conscientious work attitude, strong sense of responsibility, good communication skills, and demonstrated team organization ability.

福利待遇

Benefits and Compensation

1. 提供具有竞争力的薪酬待遇和福利，特别优秀者可一人一议；

1. Competitive salary and benefits; exceptional candidates may be considered on a case-by-case basis;

2. 符合条件者可享受有关个人所得税优惠政策和深圳市人才岗位津贴；

2. Eligible candidates may enjoy relevant personal income tax incentives and Shenzhen talent post allowances;

3. 提供充足的实验办公空间，根据人才情况予以科研启动经费；

3. Sufficient laboratory and office space, with research start-up funds provided based on individual circumstances.

4. 支持团队招收博士后科研人员，并给予丰厚的校内资助；

4. Support for recruiting postdoctoral researchers, with generous in-university funding;

5. 提供低于市场价格租赁的人才住房，符合深圳市政府相关人才政策者，可申请人才住房配售；

5. Talent housing available at below-market rental rates; those eligible under Shenzhen municipal talent policies may apply for talent housing purchase allocation;

6. 具有涵盖幼儿园、小学、初中、高中全体系的高水准附属教育机构，提供优质教育资源；

6. High-standard affiliated educational institutions covering the full spectrum from kindergarten through primary, middle, and high school, providing quality educational resources;

7. 为人才提供高水准医疗保障，提供高端人才保健体检；

7. High-level medical coverage and premium health check-ups for talents;

8. 可落户深圳市，配偶及未成年子女可办理随迁入户。

8. Shenzhen hukou (household registration) available; spouse and minor children may apply for dependent household relocation.

注：相关政策变动均以广东省、深圳市文件为准。

Note: Any changes to relevant policies shall be subject to the official documents of Guangdong Province and Shenzhen Municipality.

工作地点及申请方式

Work Location and Application Method

工作地点

Work Location

深圳市光明区新湖街道公常路1号深圳理工大学

Shenzhen University of Advanced Technology, No. 1 Gongchang Road, Xinhu Subdistrict, Guangming District, Shenzhen

申请方式

Application Method

请将个人简历、研究经历及代表性成果等以下证明材料发送至研究院招聘邮箱：IAT_recruit@

Please send your CV, research experience, representative achievements, and the following supporting materials to the Institute's recruitment email: IAT_recruit@

1. 完整简历；

1. Complete CV;

2. 研究计划和教学理念陈述；

2. Research plan and teaching philosophy statement;

3. Web of Science或Google Scholar的学术档案（包括h-index以及引用情况等）；

3. Academic profile on Web of Science or Google Scholar (including h-index and citation metrics);

4. 最高学历、学位证书；职称、职务、奖励等证书及其他重要支撑材料。

4. Highest degree certificates; certificates of professional title, position, awards, and other important supporting materials.

邮件标题请严格注明"应聘岗位（特聘教授、特聘副教授）–姓名–"，申请材料经严格筛选后，择优通知候选人进行初步交流、面试考察等后续事宜。通过简历筛选的候选人将受邀参加面试，未通过者不予另行通知。

Please strictly indicate in the email subject line: "Position Applied for (Research Professor, Associate Professor) – Full Name." After rigorous screening of application materials, shortlisted candidates will be notified for preliminary communication, interviews, and subsequent procedures. Candidates who pass the CV screening will be invited for an interview; those who do not, will not be separately notified.

本招聘长期有效，热忱期待您的加入！

This recruitment is valid on an ongoing basis. We sincerely look forward to your application!

[我要纠错]

公告热度

解锁详细分析

该公告在同类公告中的热度为 ***，目前已有 *** 对其非常感兴趣

欢迎扫描下方二维码关注官方微信公众号（硕博QQ交流群：875846081 ，进微信群qr***.cn[点击查看]" target="_blank">请点击添加官方客服号）


重要风险提示：如招聘单位在招聘过程中向求职者提出收取押金、保证金、体检费、材料费、成本费，或指定医院体检等，求职者有权要求招聘单位出具物价部门批准的收费许可证明材料，若无法提供相关证明，请求职者提高警惕，有可能属于诈骗或违规行为。